Additionally, the CNR1 (cannabinoid receptor 1) has been identified as a promising drug target for the treatment of obesity, with CNR1 knockout in mice resulting in improvements in insulin resistance, ER stress, and lipid accumulation [73]. Here, CNR1 is linked to obesity disorder.